Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

5-HT1B receptor antagonists claimed by SKB

June 25, 1997

Centrally active muscarinic agents from American Home Products

June 25, 1997

NOS inhibitors disclosed by Astra for stroke and other disorders

June 25, 1997

Boehringer Ingelheim discloses tachykinin antagonists

June 25, 1997

Safety and pharmacokinetics of JTP-4819 in healthy volunteers

June 24, 1997

SmithKline Beecham introduces ReQuip in Germany

June 24, 1997

Schering-Plough isolates potential lead for new schizophrenia drugs from Chinese plant

June 24, 1997

Lilly licenses Prozac patent rights from Interneuron for PMS treatment

June 24, 1997

MS&D describes potent and selective 5-HT1Dalpha receptor agonists

June 24, 1997

Agents for depression and related disorders from American Home Products

June 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 12, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 12, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld Science
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld Science
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...